UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 29, 2010

DUSA PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

New Jersey (State or other jurisdiction of incorporation)		001-31533 (Commission File Number)		22-3103129 (IRS Employer Identification Number)

25 Upton Drive
Wilmington, Massachusetts 01887
(Address of principal executive offices, including ZIP code)

(978) 657-7500
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o		Soliciting material pursuant to Rule 14a-12 under the Securities Act (17 CFR 240.14a-12)

o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

ITEM 5.07		Submission of Matters to a Vote of Security Holders

     (a) The Registrant held its Annual Meeting of Shareholders on July 29, 2010.

     (b) Proxies for the Annual Meeting of Shareholders were solicited pursuant to Regulation 14A of the Exchange Act; there was no solicitation in opposition to management’s nominees for directors as listed in the Proxy Statement and all such nominees were elected. The final results of the voting for eight directors for a term until the 2011 Annual Meeting of Shareholders are set forth below:

Proposal No. 1 — Election of Directors — Approved

		Votes For				Withheld				Broker non-votes
Alfred Altomari			16,740,266				211,668				-0-
David M. Bartash			15,184,704				1,767,230				-0-
Alexander W. Casdin			16,724,294				227,640				-0-
Robert F. Doman			16,654,144				297,790				-0-
Jay M. Haft, Esq.			15,184,756				1,767,178				-0-
Paul J. Hondros			16,737,818				214,116				-0-
Magnus Moliteus			15,184,456				1,767,478				-0-
David M. Wurzer, CPA			16,739,988				211,946				-0-

     Described below is the other matter voted upon at the Annual Meeting of Shareholders and the final number of affirmative votes, negative votes, abstentions and broker non-votes.

Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Registrant for the fiscal year ending December 31, 2010.

Votes For		Votes Against		Abstentions		Broker non-votes
21,409,327		241,722		13,960		-0-

     (c) On May 13, 2010, the Registrant filed a Form 8-K describing the terms of an agreement with SRB Management, L.P., SRB Greenway Opportunity Fund, (QP), L.P., SRB Greenway Opportunity Fund, L.P., BC Advisors, LLC, Steven R. Becker and Matthew A.

Drapkin to avoid a proxy contest for the election of directors at the 2010 Annual Meeting of Shareholders. The full agreement is attached as Exhibit 10.1 to the Form 8-K which is incorporated by reference therein.

     The Registrant thanks its former directors, Richard Lufkin, John Abeles and Marvin Lesser for their service to the Registrant.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.